Skip to content

{ Monthly Archives } July 2006

Effects of botulinum toxin-A on gait velocity, step length, and base of support of patients with dynamic equinovarus foot.

by Matteo Cioni, MD, Alberto Esquenazi, MD, Barbara Hirai, BS.Department of Experimental and Clinical Pharmacology, Medical School, University of Catania, Catania, Italy. OBJECTIVE: The aim of this study was to identify if botulinum toxin type A is a drug able to modify walking velocity, step length, and width of the base of support of adult [...]

Jul 1, 2006 Diseases & Disorders
Functional Domains & Other Topics
Gait
Research Comments (0) Permalink

The accuracy of artificial neural networks in predicting long-term outcome after traumatic brain injury.

by Mary E. Segal, PhD, Philip H. Goodman, MD, MS, Richard Goldstein, PhD, Walter Hauck, PhD, John Whyte, MD, PhD, John W. Graham, PhD, Marcia Polansky, ScD, Flora M. Hammond, MD. Research Center for Health Care Decision-making, Inc, Wyndmoor, PA, USA. OBJECTIVE: This study compared the accuracy of artificial neural networks to multiple regression and [...]

Jul 1, 2006 Brain injury
Diseases & Disorders Comments (0) Permalink

Cognitive rehabilitation interventions for executive function: moving from bench to bedside in patients with traumatic brain injury.

by Kevin Cicerone, Harvey Levin, James Malec, Donald Stuss, John Whyte, MD, PhD. JFK Johnson Rehabilitation Institute. Executive function mediated by prefrontally driven distributed networks is frequently impaired by traumatic brain injury (TBI) as a result of diffuse axonal injury and focal lesions. In addition to executive cognitive functions such as planning and working memory, [...]

Jul 1, 2006 Attention
Diseases & Disorders
Stroke Comments (0) Permalink

Amantadine treatment of hemispatial neglect: a double-blind, placebo-controlled study.

by Laurel J. Buxbaum, PsyD, Mary Ferraro, John Whyte, PhD, Arthur Gershkoff, H. Branch Coslett, MD.Moss Rehabilitation Research Institute, Albert Einstein Healthcare Network, Philadelphia, PA, USA. OBJECTIVE: The resemblance of some aspects of the hemispatial neglect syndrome (hypokinesia, decreased arousal) to aspects of Parkinsonian syndromes, and the success of amantadine in treating disorders of attention, [...]

Jul 1, 2006 Diseases & Disorders
Research
Stroke Comments (0) Permalink

Effects of botulinum toxin-A on gait velocity, step length, and base of support of patients with dynamic equinovarus foot

by Matteo Cioni, MD; Alberto Esquenazi, MD; Barbara Hirai, BS Department of Experimental and Clinical Pharmacology, Medical School, University of Catania, Catania, Italy. OBJECTIVE: The aim of this study was to identify if botulinum toxin type A is a drug able to modify walking velocity, step length, and width of the base of support of [...]

Jul 1, 2006 Functional Domains & Other Topics
Gait
Research Comments (0) Permalink